How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Blood Tubing Sets Market
- By Material Type: PVC (Polyvinyl Chloride), Silicone, Polyurethane, Latex-Free Materials, Thermoplastic Elastomers
- By Application: Blood Collection, Blood Transfusion, Blood Apheresis, Hemodialysis, Laboratory Testing
- By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Ambulatory Surgical Centers, Research Institutes
- By Connection Type: Luer Lock, Luer Slip, Quick Connect, Barbed Fittings, Threaded Connectors
- By Sterilization Method: Ethylene Oxide (EO) Sterilization, Gamma Radiation Sterilization, Electron Beam Sterilization, Steam Sterilization (Autoclave)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - PVC (Polyvinyl Chloride) leads By Material Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 300 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.184 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.192 →
Full report · locked preview
Everything inside the Blood Tubing Sets Market report
A complete, evidence-based study - 12 chapters and 126 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Material Type 5
Application 5
End User 5
Connection Type 5
Sterilization Method 4
Companies profiled
B. Braun Melsungen AG
Fresenius Kabi AG
Terumo Corporation
Nipro Corporation
Baxter International Inc.
Medtronic plc
Smiths Medical (ICU Medical)
Ningbo David Medical Device Co. Ltd.
JMS Co. Ltd.
Becton
Dickinson and Company (BD)
Asahi Kasei Medical Co. Ltd.
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →B. Braun Melsungen AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Fresenius Kabi AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Nipro Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Baxter International Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Smiths Medical (ICU Medical)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Ningbo David Medical Device Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →JMS Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Becton
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Dickinson and Company (BD)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Asahi Kasei Medical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Ningbo Tianan Medical Device Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Nipro Medical Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →
Global · 2025–2033
$4,363M by 2033 · 9.4% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- PVC (Polyvinyl Chloride)31.9
- Silicone14.7
- Polyurethane21.0
- Latex-Free Materials20.5
- Thermoplastic Elastomers11.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$703.2M → $1,369M · 8.7%
Europe$490.1M → $1,028M · 9.7%
Asia Pacific$447.5M → $847.2M · 8.3%
Latin America$277.0M → $521.1M · 8.2%
Middle East and Africa$213.1M → $417.6M · 8.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.332026
9.332027
9.342028
9.352029
9.372030
9.382031
9.392032
9.412033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- B. Braun Melsungen AG8.9
- Fresenius Kabi AG17.7
- Terumo Corporation8.2
- Nipro Corporation13.9
- Baxter International Inc.10.8
- Medtronic plc12.4
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Material Type20.3%
Application20.7%
End User28.6%
Connection Type13.8%
Sterilization Method16.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.7
- Europe24.6
- Asia Pacific20.3
- Latin America12.5
- Middle East and Africa10.0
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| B. Braun Melsungen AG | 86 | 88 | 99 | 90 | 93 | 96 | 92 |
| Fresenius Kabi AG | 72 | 77 | 71 | 87 | 88 | 89 | 81 |
| Terumo Corporation | 72 | 69 | 71 | 87 | 72 | 78 | 75 |
| Nipro Corporation | 67 | 72 | 57 | 67 | 75 | 80 | 70 |
| Baxter International Inc. | 52 | 76 | 60 | 53 | 62 | 55 | 60 |
| Medtronic plc | 69 | 50 | 62 | 54 | 54 | 55 | 57 |
| Smiths Medical (ICU Medical) | 56 | 40 | 64 | 48 | 56 | 65 | 55 |
| Ningbo David Medical Device Co. Ltd. | 50 | 51 | 52 | 41 | 56 | 59 | 52 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- B. Braun Melsungen AG
- Fresenius Kabi AG
- Terumo Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| B. Braun Melsungen AG | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Fresenius Kabi AG | ✓ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Terumo Corporation | ✓ | ◐ | − | ✓ | − | ✓ |
| Nipro Corporation | ◐ | ✓ | − | ✓ | ◐ | ◐ |
| Baxter International Inc. | ◐ | ◐ | − | − | ◐ | − |
| Medtronic plc | ◐ | − | ◐ | − | ◐ | ◐ |
| Smiths Medical (ICU Medical) | ◐ | − | ◐ | ◐ | − | ◐ |
| Ningbo David Medical Device Co. Ltd. | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1B. Braun Melsungen AG92
2Fresenius Kabi AG81
3Terumo Corporation75
4Nipro Corporation70
5Baxter International Inc.60
6Medtronic plc57
7Smiths Medical (ICU Medical)55
8Ningbo David Medical Device Co. Ltd.52
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
B. Braun Melsungen AGFresenius Kabi AG
Challenger2
Strong scale, closing on the leaders.
Terumo CorporationNipro Corporation
Contender2
Focused players with pockets of strength.
Baxter International Inc.Medtronic plc
Niche2
Specialists in a single segment or region.
Smiths Medical (ICU Medical)Ningbo David Medical Device Co. Ltd.
Go-to-market strategy
Land Material Type in North America, then scale across Blood Tubing Sets Market — a $44M beachhead inside a $662M market.
Beachhead (SOM)$44Mobtainable near-term
Serviceable (SAM)$258Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
PVC (Polyvinyl Chloride)
Best fit — highest urgency & budget in Material Type.
Economic buyer80 fit
Silicone
Strong fit — clear ROI and a fast path to value.
End user68 fit
Polyurethane
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Material Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel28%
Digital / self-serve18%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Material Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Blood Tubing Sets Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified22%
Evaluation12%
Closed-won5%
$10.4KCAC
$60KLTV
5.7:1LTV : CAC
< 4 moCAC payback
Investment thesis
Blood Tubing Sets Market is a high-growth opportunity — $11.4B by 2033, compounding at 11.7%.
TAM · 2025$4.71Btoday
TAM · 2033$11.4Bforecast
CAGR11.7%2027–2033
Cumulative$68.6Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$11.4BTotal addressable market
SAM$3.90BServiceable available market
SOM$656MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.7% CAGR
Demand compounds through 2033, outpacing GDP across Material Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Material Type moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$11.4BLarge & growingTAM by 2033 at 11.7% CAGR
$3.90BServiceable nowreachable with today’s model
$656MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$8.88BBear7.6% CAGR
$11.4BBase11.7% CAGR
$14.6BBull15.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Blood Tubing Sets Market — a $3.13B market by 2033. Plan: grow share from 5.2% to 11.1%.
Market size · 2033$3.13Btotal addressable
Market CAGR5.9%2027–2033
Target share11.1%from 5.2% today
Revenue ambition$348Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 5.2% | 11.1% | On track |
| Revenue | $161M | $348M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 28.2% | 41.8% | On track |
| Customer retention | 91.8% | 92.3% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Material Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Material Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $47M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Material Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeBehind
- Execution & talentBehind
Sales deck · value proposition
Win the Blood Tubing Sets Market conversation — a $1.03B market you can size, segment and defend in minutes.
Market size · 2033$1.03Btotal opportunity
Growth3.7%CAGR to 2033
Addressable buyers1,058+accounts in scope
Typical ROI4.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Material Type
Goal Grow share in Material Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.5×return on cost, year one
< 3 mopayback period
$83K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
B. Braun Melsungen AGFresenius Kabi AGTerumo CorporationNipro CorporationBaxter International Inc.Medtronic plcSmiths Medical (ICU Medical)Ningbo David Medical Device Co. Ltd.+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Blood Tubing Sets Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Blood Tubing Sets Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Blood Typing, Groupng And Infectious Disease Screening Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportBlood Warmer Devices/Sample Warmer Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportBlood Warming Devices Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportBlood/IV Warmers Market
Market size, share, segmentation and regional forecast.
$347M market · 2025 base year
View reportBlood-drawing Robot Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportBloodstock Insurance Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportBloodsugar(glocose)analyzer Market
Market size, share, segmentation and regional forecast.
$650M market · 2025 base year
View reportBlotting Instrument Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportBlotting Tanks Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportBlow Dryers Market
Market size, share, segmentation and regional forecast.
$396M market · 2025 base year
View reportBlow Gun Accessorie Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportBlow Gun Market
Market size, share, segmentation and regional forecast.
$701M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.